(Q37869767)

24 August 2017

1 reference

title

Role of the endocannabinoid system in alcoholic liver disease (English)

1 reference

24 August 2017

main subject

endocannabinoid system

0 references

author name string

S V Siegmund

series ordinal

1

1 reference

24 August 2017

publication date

1 January 2010

1 reference

24 August 2017

1 reference

24 August 2017

volume

28

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

751-755

1 reference

Molecular pathogenesis of alcohol-induced hepatic fibrosis

24 August 2017

cites work

1 reference

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

The endocannabinoid system and its therapeutic exploitation

21 January 2018

1 reference

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

Brain monoglyceride lipase participating in endocannabinoid inactivation

21 January 2018

1 reference

Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases

21 January 2018

1 reference

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

21 January 2018

1 reference

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

21 January 2018

1 reference

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

21 January 2018

1 reference

The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease

21 January 2018

1 reference

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

21 January 2018

1 reference

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis

21 January 2018

1 reference

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

21 January 2018

1 reference

Anandamide induces necrosis in primary hepatic stellate cells

21 January 2018

1 reference

Fatty acid amide hydrolase determines anandamide-induced cell death in the liver

21 January 2018

1 reference

Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice

21 January 2018

1 reference

Gene expression profiles during hepatic stellate cell activation in culture and in vivo

21 January 2018

1 reference

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000324283

1 reference

24 August 2017

1 reference